Capitaux Propres Et Réserves Changement Date
Cara Therapeutics USD 20.95M 6.92M 2025-12
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 95.35M 7.38M 2026-03
Cronos Group USD 1.07B 20.24M 2026-03
RedHill Biopharma USD 4.27M 8.68M 2025-12